{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:22:02Z","timestamp":1793784122071,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.trim.2023.101900","type":"journal-article","created":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T09:37:37Z","timestamp":1688895457000},"page":"101900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Analysis of death avoidance by concomitant use of prednisone in patients with renal transplant using the Food and Drug Administration Adverse Event Reporting System"],"prefix":"10.1016","volume":"80","author":[{"given":"Toru","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Urawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00281-011-0259-7","article-title":"Steroids in kidney transplant patients","volume":"33","author":"Steiner","year":"2011","journal-title":"Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.trim.2023.101900_bb0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","article-title":"Tacrolimus","volume":"46","author":"Peters","year":"1993","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.trim.2023.101900_bb0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-199754060-00009","article-title":"Tacrolimus","volume":"54","author":"Spencer","year":"1997","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2165\/00003495-199651020-00007","article-title":"Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation","volume":"51","author":"Fulton","year":"1996","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.trim.2023.101900_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2004.04.003","article-title":"Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment","volume":"13","author":"Hutchinson","year":"2004","journal-title":"Transpl. Immunol."},{"issue":"6","key":"10.1016\/j.trim.2023.101900_bb0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2165\/00003495-199345060-00007","article-title":"Cyclosporin","volume":"45","author":"Faulds","year":"1993","journal-title":"Drugs"},{"issue":"13","key":"10.1016\/j.trim.2023.101900_bb0035","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2165\/00003495-200161130-00006","article-title":"Cyclosporin","volume":"61","author":"Dunn","year":"2001","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.trim.2023.101900_bb0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.trim.2023.101900_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00003495-200666040-00009","article-title":"Everolimus","volume":"66","author":"Dunn","year":"2006","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.trim.2023.101900_bb0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.20377","article-title":"Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation","volume":"11","author":"Breen","year":"2005","journal-title":"Liver Transpl."},{"issue":"1","key":"10.1016\/j.trim.2023.101900_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003495-199958010-00010","article-title":"Rituximab","volume":"58","author":"Czuczman","year":"1999","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.trim.2023.101900_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003495-199958010-00011","article-title":"Rituximab","volume":"58","author":"Leporrier","year":"1999","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1328-8067.2001.01531.x","article-title":"Role of mizoribine in renal transplantation","volume":"44","author":"Tsuzuki","year":"2002","journal-title":"Pediatr. Int."},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00003495-199957020-00006","article-title":"Basiliximab","volume":"57","author":"Onrust","year":"1999","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.trim.2023.101900_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trim.2012.03.006","article-title":"Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients","volume":"27","author":"Li","year":"2012","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2023.101900_bb0080","author":"Food and Drug Administration"},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40261-022-01242-7","article-title":"Comparison of adverse events occurred during administration of dipeptidyl peptidase-4 inhibitor in patients with diabetes using FDA Adverse Event Reporting System","volume":"43","author":"Ogura","year":"2023","journal-title":"Clin. Drug Investig."},{"issue":"3","key":"10.1016\/j.trim.2023.101900_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.yrtph.2015.05.004","article-title":"Comedications alter drug-induced liver injury reporting frequency: data mining in the WHO VigiBase\u2122","volume":"72","author":"Suzuki","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.trim.2023.101900_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060425","article-title":"Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination","volume":"12","author":"Lane","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.21873\/anticanres.16231","article-title":"Analysis of clinical factors in olaparib-related anemia using adverse drug event reporting databases","volume":"43","author":"Shiraishi","year":"2023","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.trim.2023.101900_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratio of frequencies","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann. Hum. Genet."},{"issue":"1\/2","key":"10.1016\/j.trim.2023.101900_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2307\/2333861","article-title":"On the bias of various estimators of the logit and its variance with application to quantal bioassay","volume":"54","author":"Gart","year":"1967","journal-title":"Biometrika"},{"key":"10.1016\/j.trim.2023.101900_bb0115","series-title":"Statistical Analysis with Missing Data","author":"Little","year":"2019"},{"key":"10.1016\/j.trim.2023.101900_bb0120","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"issue":"3","key":"10.1016\/j.trim.2023.101900_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0966-3274(97)80042-1","article-title":"Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings","volume":"5","author":"Zucker","year":"1997","journal-title":"Transpl. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trim.2014.06.001","article-title":"Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil","volume":"31","author":"Kabei","year":"2014","journal-title":"Transpl. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trim.2015.07.005","article-title":"Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: results from a single-center randomized trial","volume":"33","author":"Libetta","year":"2015","journal-title":"Transpl. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2023.101900_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2023.101900_bb0145","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1248\/bpb.34.1578","article-title":"Steroid withdrawal based on lymphocyte sensitivity to endogenous steroid in renal transplant recipients","volume":"34","author":"Takeuchi","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.trim.2023.101900_bb0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/10543406.2022.2154940","article-title":"Parameter estimation of Weibull distribution for the number of days between drug administration and early onset adverse event","author":"Ogura","year":"2023","journal-title":"J. Biopharm. Stat.33"},{"key":"10.1016\/j.trim.2023.101900_bb0155","author":"European Medicines Agency"},{"key":"10.1016\/j.trim.2023.101900_bb0160","author":"Uppsala Monitoring Centre"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742300117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742300117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:04:16Z","timestamp":1760810656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742300117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":32,"alternative-id":["S096632742300117X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101900","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of death avoidance by concomitant use of prednisone in patients with renal transplant using the Food and Drug Administration Adverse Event Reporting System","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101900"}}